{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:22:19Z","timestamp":1768486939288,"version":"3.49.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1097\/bor.0000000000000046","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T08:44:19Z","timestamp":1395391459000},"page":"341-346","source":"Crossref","is-referenced-by-count":17,"title":["Rheumatoid arthritis and pregnancy"],"prefix":"10.1097","volume":"26","author":[{"given":"Marvin","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza F.","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-16-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/14767058.2012.664943","article-title":"Congenital malformations.","volume":"25","author":"Corsello","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R5-16-20210128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/dth.12015","article-title":"Safety classification systems used in dermatological medication risk counseling of pregnant and lactating patients: a case for an evidencebased approach.","volume":"26","author":"Millsop","year":"2013","journal-title":"Dermatol Ther"},{"key":"R6-16-20210128","first-page":"21","article-title":"T2T: dont forget pregnant patients.","volume":"6","author":"Chakravarty","year":"2012","journal-title":"Rheumatologists"},{"key":"R7-16-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/bdra.20533","article-title":"Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines.","volume":"85","author":"Carey","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R8-16-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajmg.c.30309","article-title":"We dont know what we dont study: the case for research on medication effects in pregnancy.","volume":"157C","author":"Parisi","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R9-16-20210128","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.080545","article-title":"A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database.","volume":"36","author":"Carter","year":"2009","journal-title":"J Rheumatol"},{"key":"R10-16-20210128","first-page":"465","article-title":"Do tumor necrosis factor inhibitors cause malformations in humans J R","volume":"36","author":"Koren","year":"2009","journal-title":"heumatol"},{"key":"R11-16-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.1.2.6","article-title":"Safety of tumor necrosis factor inhibitors during pregnancy and breastfeeding.","volume":"1","author":"Raja","year":"2012","journal-title":"Transl Vis Sci Technol"},{"key":"R12-16-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2013.05.006","article-title":"Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy.","volume":"149","author":"Barbhaiya","year":"2013","journal-title":"Clin Immunol"},{"key":"R13-16-20210128","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/art.24003","article-title":"Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study.","volume":"59","author":"de Man","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R14-16-20210128","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/art.24914","article-title":"Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results from a national prospective registry.","volume":"60","author":"De Man","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R15-16-20210128","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/art.30206","article-title":"Rheumatoid arthritis and pregnancy: beyond smaller and preterm babies.","volume":"63","author":"Chakravarty","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R16-16-20210128","first-page":"9","article-title":"High rate of preterm birth in pregnancies complicated by rheumatoid arthritis.","volume":"31","author":"Langen","year":"2014","journal-title":"Am J Perinatol"},{"key":"R17-16-20210128","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.30210","article-title":"Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth.","volume":"63","author":"Wallenius","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R18-16-20210128","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/bdra.23033","article-title":"Emerging data on the use of antitumor necrosis factor-alpha medications in pregnancy.","volume":"94","author":"Chambers","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R19-16-20210128","doi-asserted-by":"crossref","first-page":"985646","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies.","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"R20-16-20210128","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/S0264-410X(03)00334-7","article-title":"Placental transport of immunoglobulin G.","volume":"21","author":"Simister","year":"2003","journal-title":"Vaccine"},{"key":"R21-16-20210128","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1741-7015-11-174","article-title":"Safety of TNF-a inhibitors during IBD pregnancy: a systematic review.","volume":"11","author":"Nielsen","year":"2013","journal-title":"BMC Med"},{"key":"R22-16-20210128","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S0016-5085(12)60561-7","article-title":"PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy. Updated presentation at the DDW 2012.","volume":"142","author":"Mahadevan","year":"2012","journal-title":"Gastroenterology"},{"key":"R23-16-20210128","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/03009742.2011.626442","article-title":"Outcomes after antirheumatoid drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.","volume":"41","author":"Viktil","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"R24-16-20210128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2013.11.004","article-title":"Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study.","volume":"43","author":"Diav-Citrin","year":"2014","journal-title":"Reprod Toxicol"},{"key":"R25-16-20210128","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab.","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"R26-16-20210128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/rheumatology\/kes164","article-title":"Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman.","volume":"52","author":"Martinez-Martinez","year":"2013","journal-title":"Rheumatology"},{"key":"R27-16-20210128","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of antitumor necrosis factor agents in pregnant patients with inflammatory bowel disease.","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R28-16-20210128","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohns Disease.","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:31:51Z","timestamp":1620948711000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201405000-00016"}},"subtitle":["impediments to optimal management of both biologic use before, during and after pregnancy"],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000046","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}